The format consists of three modules, beginning on Saturday morning and finishing on Sunday afternoon. Each module comprises short state-of-the-art lectures followed by debates, case reports and interactive discussions. 

Friday, 25 June 2010
17.00 – 20.00	Registration
Saturday, 26 June 2010
07.00 – 08.00	Registration
08.00 - 08.30	EBU Pre-assessment
08.30 – 12.30	Teaching modules 1 – 3
12.30 – 14.00	Break
14.00 – 18.00	Teaching modules 1 – 3
Sunday, 27 June 2010
08.30 – 12.30	Teaching modules 1 – 3
12.30 – 13.00	Break
13.00 – 15.00	EBU Examination

Module 1: Hormonal and intravesical treatment and chemoprevention
Chair: H-P. Schmid, St. Gallen (CH)

Prevention of prostate and bladder cancer
N. Mottet, Saint Etienne (FR)
Intravesical therapy
A. Bohle, Bad Schwartau (DE)
Hormones
H-P. Schmid, St. Gallen (CH)

Module 2: Immunotherapy and targeted therapies
Chair: P. Mulders, Nijmegen (NL)

Immunotherapy and vaccines
P. Mulders, Nijmegen (NL)
Targeted therapies
M. Schmidinger, Vienna (AT)
Bone therapies
S. Joniau, Leuven (BE)

Module 3: Systemic cytotoxic chemotherapy and palliation
Chair: N. Clarke, Manchester (GB)

Testis cancer
Z. Kirkali, Izmir (TR)
Bladder cancer
N. Clarke, Manchester (GB)
Prostate cancer
M. Kuczyk, Hannover (DE)

Course directors
H. Van Poppel, Leuven (BE)
Z. Kirkali, Izmir (TR)

Faculty
A. Bohle, Bad Schwartau (DE)
N. Clarke, Manchester (GB)
S. Joniau, Leuven (BE)
Z. Kirkali, Izmir (TR)
M. Kuczyk, Hannover (DE)
N. Mottet, Saint Etienne (FR)
P. Mulders, Nijmegen (NL)
H-P. Schmid, St. Gallen (CH)
M. Schmidinger, Vienna (AT)